MELOTTI, Paola Maria
 Distribuzione geografica
Continente #
NA - Nord America 3.750
EU - Europa 3.604
AS - Asia 2.699
SA - Sud America 416
AF - Africa 32
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.514
Nazione #
US - Stati Uniti d'America 3.654
CN - Cina 1.099
GB - Regno Unito 1.081
SG - Singapore 932
RU - Federazione Russa 812
IT - Italia 365
BR - Brasile 364
SE - Svezia 287
DE - Germania 265
HK - Hong Kong 229
IE - Irlanda 201
FR - Francia 200
FI - Finlandia 190
VN - Vietnam 125
KR - Corea 75
CA - Canada 68
TR - Turchia 49
UA - Ucraina 42
JP - Giappone 34
ID - Indonesia 32
IN - India 31
NL - Olanda 29
BE - Belgio 28
ES - Italia 24
PL - Polonia 24
AT - Austria 22
MX - Messico 20
AR - Argentina 18
IQ - Iraq 14
BD - Bangladesh 11
IR - Iran 11
ZA - Sudafrica 10
EC - Ecuador 9
UZ - Uzbekistan 9
VE - Venezuela 8
CZ - Repubblica Ceca 7
PK - Pakistan 7
PY - Paraguay 7
IL - Israele 6
LT - Lituania 6
TG - Togo 6
AU - Australia 5
NP - Nepal 5
AZ - Azerbaigian 4
CO - Colombia 4
JO - Giordania 4
LV - Lettonia 4
MA - Marocco 4
NZ - Nuova Zelanda 4
PE - Perù 4
DO - Repubblica Dominicana 3
LU - Lussemburgo 3
PT - Portogallo 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
CH - Svizzera 2
EG - Egitto 2
KG - Kirghizistan 2
PH - Filippine 2
PS - Palestinian Territory 2
TN - Tunisia 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CD - Congo 1
CG - Congo 1
CL - Cile 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
EU - Europa 1
HN - Honduras 1
IS - Islanda 1
JM - Giamaica 1
KE - Kenya 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LY - Libia 1
MY - Malesia 1
NE - Niger 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PG - Papua Nuova Guinea 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 10.514
Città #
Southend 964
Chandler 581
Dallas 388
Singapore 377
Jacksonville 291
Woodbridge 289
Ashburn 239
Hong Kong 227
Ann Arbor 220
Moscow 206
Beijing 203
Dublin 197
Verona 165
Houston 149
New York 117
Munich 92
Jinan 91
Wilmington 83
Princeton 72
Lawrence 71
Nanjing 71
Shenyang 70
Dong Ket 61
Los Angeles 58
Turku 45
Helsinki 40
Hebei 35
Seoul 35
Tianjin 34
Nanchang 33
Redondo Beach 33
Ningbo 31
Guangzhou 30
Haikou 29
Brussels 27
Buffalo 27
Jakarta 27
Santa Clara 27
Zhengzhou 27
Changsha 26
Lancaster 26
Hangzhou 24
Jiaxing 24
Taiyuan 24
Tokyo 24
Sindelfingen 23
Taizhou 23
São Paulo 22
Milan 20
Brooklyn 19
The Dalles 19
Toronto 19
Columbus 18
Fairfield 18
San Francisco 18
Vienna 18
Falls Church 17
Montreal 17
Seattle 17
Stockholm 17
Boardman 16
Council Bluffs 16
London 16
Warsaw 16
Madrid 14
Nuremberg 14
Frankfurt am Main 13
Amsterdam 12
Bologna 12
Boston 12
Lappeenranta 12
Elora 11
Norwalk 11
Phoenix 11
Rio de Janeiro 11
Washington 11
Chicago 10
Ho Chi Minh City 10
Poplar 10
Redwood City 10
Belo Horizonte 9
Chennai 9
Kent 9
Orem 9
Redmond 9
Rome 9
Tashkent 9
Brasília 8
Mexico City 8
Atlanta 7
Curitiba 7
Dongguan 7
Hanoi 7
Johannesburg 7
Lanzhou 7
Riva del Garda 7
Auburn Hills 6
Augusta 6
Cambridge 6
Charlotte 6
Totale 6.595
Nome #
Development of FT-IR microspectroscopy for pre-clinical and clinical applications 284
Functional Evaluation of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) in human monocytes 227
Defective CFTR expression and function are detectable in blood monocytes: development of a new blood test for cystic fibrosis. 206
Detection of CFTR protein in human leukocytes by flow cytometry. 198
Virulence and antibiotic resistance of Achromobacter spp. isolates from chronic and occasional lung infection in cystic fibrosis patients 198
Analysis of CFTR function in human monocytes 196
Azithromycin (AZM) decreases Glutathione-S-Transferase (GST) -T1 expression and activity in CF airway epithelial cells. 191
Analysis of proteins released from Pseudomonas aeruginosa clinical and laboratory strains: effects of azithromycin 186
Azithromycin (AZM) decreases Glutathione-S-Transferase (GST) - T1 expression and activity in CF airway epithelial cells 178
Analysis of Pseudomonas Aeuginosa secretome: consequences of oxygen limitation in clinical and laboratory strains 170
Combining standardized and new CFTR functional tests for diagnosis 170
Biogenic selenium nanoparticles: characterization, antimicrobial activity and effects on human dendritic cells and fibroblasts 168
MudPIT analysis of released proteins in Pseudomonas aeruginosa laboratory and clinical strains in relation to pro-inflammatory effects 166
Azithromicin decreases elevated glutathione-S-transferase T1 (GSTT1) and M1 (GSTM1) expression and activity in cystic fibrosis airways epithelial cells 165
P139 Hypermutation as an evolutionary mechanism for Achromobacter spp. in cystic fibrosis lung infection 165
Proteins released from Pseudomonas aeruginosa (Pa) referent and clinical strains under microaerobiosis and their effects on cystic fibrosis airways 160
An interactive computer program can effectively educate potential users of cystic fibrosis carrier tests. 159
WS18.3 A combination of CFTR functional tests supporting drug development and diagnosis: the contribution of intestinal epithelial organoids 159
Mutations of Cystic Fibrosis Transmembrane Conductance Regulator Gene Cause a Monocyte-Selective Adhesion Deficiency. 158
An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses 156
Impaired CFTR function in mild cystic fibrosis associated with the S977F/T5TG12complex allele in trans with F508del mutation. 151
14 Standardized protocol for ratiometric measurement of b-adrenergic/cholinergic sweating in human sweat glands 149
IMPAIRED CFTR FUNCTION IN MILD CF ASSOCIATED WITH THE S977F/T5TG12 COMPLEX ALLELE 148
Poster Session Abstracts 148
Impact of polymorphism of Multidrug Resistance-associated Protein 1 (ABCC1) gene on the severity of cystic fibrosis. 146
In vivo monitoring of lung inflammation in CFTR-deficient mice 146
New potential biomarkers for the management of cystic fibrosis: measurements of CFTR expression & function in human leukocytes. 145
Inhibition of Pseudomonas aeruginosa secreted virulence factors reduces lung inflammation in CF mice 145
Impaired CTFR function in mild CF associated with the S977F/T5TG12 complex allele. 143
ePS01.7 Supporting diagnosis with a combination of standardized and new CFTR functional tests 142
New clinical diagnostic procedures for cystic fibrosis in Europe. 141
22 Testing flow cytometry to detect CFTR expression recovery after drug treatment in epithelial cell lines 141
AZITHROMYCIN EFFECT ON LUNG INFLAMMATION INDUCED BY PSEUDOMONAS AERUGINOSA RELEASED PROTEASES AS SHOWN BY IN VIVO IMAGING IN IL-8 TRANSIENTLY TRANSGENIZED MICE 141
Intestinal epithelial organoids contribute to combination of CFTR functional tests supporting drug development and diagnosis 138
DEVELOPMENT OF A CF, IL-8 TRANSGENIC MOUSE MODEL FOR THE IN VIVO LONG-TERM MONITORING OF LUNG INFLAMMATION 138
Protein Tyrosine Phosphatase Gamma (PTPgamma) is a Novel Leukocyte Marker Highly Expressed by CD34 Precursors 135
20 In vivo monitoring of lung inflammation in CFTR–/– mice 135
Poster Session Abstracts 133
Whole blood fatty acid analysis with micromethod in cystic fibrosis and pulmonary disease. 132
Effects of high altitude on eosinophil protein X (EPX) serum levels and specific IgE for pteronyssinus (Dpt) and farinae (Df) in asthmatic children 130
Effects of azithromycin on glutathione S-transferases in cystic fibrosis airway cells 126
Poster Session Abstracts 126
Eosinophil activation in bronchial asthma: the role of adhesion molecules (ß1 and ß2 integrins) 123
HLA-G expression and regulation during Pseudomonas aeruginosa infection in cystic fibrosis patients 121
Guideline on the design and conduct of cystic fibrosis clinical trials: the European Cystic Fibrosis Society-Clinical Trials Network (ECFS-CTN). 119
Cystic fibrosis transmembrane conductance regulator functional evaluations in a G542X+/- IVS8Tn:T7/9 patient with acute recurrent pancreatitis 119
Achromobacter spp. adaptation in cystic fibrosis infection and candidate biomarkers of antimicrobial resistance 118
Ratiometric sweat secretion optical test in cystic fibrosis, carriers and healthy subjects 118
In vivo imaging of the lung inflammatory response to Pseudomonas aeruginosa and its modulation by azithromycin 117
MOLECULAR IMAGING OF THE ANTI-INFLAMMATORY EFFECTS OF AZITHROMYCIN IN THE LUNG 116
Azithromycin Attenuates Pseudomonas-Induced Lung Inflammation by Targeting Bacterial Proteins Secreted in the Cultured Medium 111
Poster Session Abstracts 111
Toothbrushes may convey bacteria to the cystic fibrosis lower airways 111
Mobilome analysis of Achromobacter spp. isolates from chronic and occasional lung infection in cystic fibrosis patients 110
Optical Measurements of Sweat for in Vivo Quantification of CFTR Function in Individual Sweat Glands 110
Real-Life Experience with CFTR Modulators Shows Correction of LAD-IV Phenotype in Cystic Fibrosis 109
A PI3Kγ mimetic peptide triggers CFTR gating, bronchodilation, and reduced inflammation in obstructive airway diseases 108
Genomic characterization of Achromobacter species isolates from chronic and occasional lung infection in cystic fibrosis patients 107
Longitudinal monitoring of sinonasal and oral bacterial reservoirs to prevent chronic lung infection in people with cystic fibrosis 106
IMPACT OF POLYMORPHIC-794 CATT REPEATS OF MACROPHAGE MIGRATION INHIBITORY FACTOR PROMOTER ON SEVERITY OF CF 105
Impact of the polymorphic variant 5 FR/G-260C in the Multidrug Resistance-associate Protein-1 gene on severity of cystic fibrosis 104
Receptor Protein Tyrosine Phosphatase gamma (Ptpg) regulates hematopoietic differentiation 103
The identification of cystic fibrosis (CF) cells and their pharmacological correction by mid-infrared microspectroscopy and unsupervised data analysis methods 103
Identification of Potential Leukocyte Biomarkers Related to Drug Recovery of CFTR: Clinical Applications in Cystic Fibrosis 100
PROTEOMIC ANALYSIS OF PROTEINS RELEASED FROM PSEUDOMONAS AERUGINOSA CLINICAL AND LABORATORY STRAINS: EFFECTS OF AZITHROMYCIN 93
PTX3 genetic variations affect the risk of Pseudomonas aeruginosa airway colonization in cystic fibrosis patients 91
Relevance of oxygen limitation on pseudomonas aeruginosa strains: Effects on released proteins expression 89
STANDARDIZATION OF RATIOMETRIC MEASUREMENT OF BETA ADRENERGIC/CHOLINERGIC SWEATING IN HUMAN SWEAT GLANDS 87
When and how ruling out cystic fibrosis in adult patients with bronchiectasis 87
CFTR function is impaired in a subset of patients with pancreatitis carrying rare CFTR variants 86
Oxidative stress and antioxidant therapy in cystic fibrosis 86
RELEVANCE OF HLA-G IN CF 86
The role of macrophages and their scavenger receptors in cystic fibrosis 80
Efficacy and safety of ataluren in patients with nonsense-mutation cystic fibrosis not receiving chronic inhaled aminoglycosides: the international, randomized, double-blind, placebo-controlled Ataluren Confirmatory Trial in Cystic Fibrosis (ACT CF). 80
Functional rescue of CFTR in rectal organoids from patients carrying R334W variant by CFTR modulators and PDE4 inhibitor Roflumilast 79
In Vivo Inflammation Caused by Achromobacter spp. Cystic Fibrosis Clinical Isolates Exhibiting Different Pathogenic Characteristics 79
In silico analysis and theratyping of an ultra-rare CFTR genotype (W57G/A234D) in primary human rectal and nasal epithelial cells 78
CFTR Modulators Rescue the Activity of CFTR in Colonoids Expressing the Complex Allele p.[R74W;V201M;D1270N]/dele22_24 78
Theratyping of the Rare CFTR Genotype A559T in Rectal Organoids and Nasal Cells Reveals a Relevant Response to Elexacaftor (VX-445) and Tezacaftor (VX-661) Combination 61
Adenine base editing with engineered virus-like particles rescues the CFTR mutation G542X in patient-derived intestinal organoids 57
Organoid Technology and Its Role for Theratyping Applications in Cystic Fibrosis 56
Theratyping of the Rare CFTR Variants E193K and R334W in Rectal Organoid-Derived Epithelial Monolayers 52
Evaluation of the response to elexacaftor-tezacaftor-ivacaftor of the rare CFTR variants L383S, I507del, L1065P and R1066H in intestinal organoid-derived epithelial monolayers 49
Totale 10.642
Categoria #
all - tutte 38.580
article - articoli 20.830
book - libri 0
conference - conferenze 17.750
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.160


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021366 0 0 0 0 63 49 15 31 25 2 81 100
2021/2022741 88 241 4 43 45 19 8 28 27 28 52 158
2022/20231.472 113 175 109 267 115 359 17 79 171 8 40 19
2023/2024824 52 57 51 82 79 158 33 54 37 45 126 50
2024/20252.178 98 126 82 370 80 80 177 74 308 153 245 385
2025/20262.266 404 316 412 1.023 111 0 0 0 0 0 0 0
Totale 10.642